UBS Group AG - BURNING ROCK BIOTECH LTD ownership

BURNING ROCK BIOTECH LTD's ticker is BNR and the CUSIP is 12233L107. A total of 52 filers reported holding BURNING ROCK BIOTECH LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BURNING ROCK BIOTECH LTD
ValueSharesWeighting
Q3 2023$1,673
-79.6%
1,725
-40.8%
0.00%
Q1 2023$8,191
+94.2%
2,915
+55.5%
0.00%
Q4 2022$4,217
-95.5%
1,874
-94.1%
0.00%
Q2 2022$93,000
+304.3%
31,720
+1169.8%
0.00%
Q1 2022$23,000
+76.9%
2,498
+83.3%
0.00%
Q4 2021$13,000
-99.0%
1,363
-98.2%
0.00%
Q3 2021$1,358,000
-34.2%
75,962
+8.4%
0.00%
-100.0%
Q2 2021$2,064,000
+22833.3%
70,046
+16984.4%
0.00%
Q4 2020$9,000
-89.9%
410
-87.5%
0.00%
Q2 2020$89,0003,2850.00%
Other shareholders
BURNING ROCK BIOTECH LTD shareholders Q3 2022
NameSharesValueWeighting ↓
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,990,408$35,588,0002.16%
Prince Street Capital Management LLC 184,000$3,289,0002.05%
SHEN NEIL NANPENG 885$16,0000.51%
Orbimed Advisors 1,856,201$33,189,0000.36%
HSG Holding Ltd 212,121$3,793,0000.34%
AtonRa Partners 40,701$728,0000.24%
Euro Pacific Asset Management, LLC 29,305$524,0000.14%
Bellevue Group AG 489,890$8,759,0000.09%
Baillie Gifford 8,792,152$157,204,0000.08%
Hudson Bay Capital Management LP 301,061$5,383,0000.07%
View complete list of BURNING ROCK BIOTECH LTD shareholders